{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:36:07Z","timestamp":1782779767388,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005270","name":"Fujian Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clinre.2019.04.001","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T21:13:05Z","timestamp":1557349985000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Novel predictive models using serum ceruloplasmin levels for hepatic steatosis in patients with chronic hepatitis B infection"],"prefix":"10.1016","volume":"44","author":[{"given":"Na-Ling","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ji","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Wu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinre.2019.04.001_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.clinre.2019.04.001_bib0010","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.clinre.2015.12.011","article-title":"Chronic hepatitis B and fatty liver: Issues in clinical management","volume":"40","author":"Kumar","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"9","key":"10.1016\/j.clinre.2019.04.001_bib0015","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.dld.2009.01.004","article-title":"Non-alcoholic fatty liver disease pathogenesis: the present and the future","volume":"41","author":"Petta","year":"2009","journal-title":"Digestive Liver Dis"},{"issue":"1","key":"10.1016\/j.clinre.2019.04.001_bib0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jhep.2008.10.010","article-title":"Epidemiology of non-alcoholic fatty liver disease in China","volume":"50","author":"Fan","year":"2009","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2019.04.001_bib0025","doi-asserted-by":"crossref","first-page":"e34198","DOI":"10.1371\/journal.pone.0034198","article-title":"Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B","volume":"7","author":"Jin","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.clinre.2019.04.001_bib0030","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1016\/j.transproceed.2015.10.023","article-title":"Hepatic steatosis as a predictive factor of antiviral effect of pegylated interferon therapy in patients with hepatitis B","volume":"47","author":"Gong","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinre.2019.04.001_bib0035","doi-asserted-by":"crossref","first-page":"1096406","DOI":"10.1155\/2017\/1096406","article-title":"The effect of hepatosteatosis on response to antiviral treatment in patients with chronic hepatitis B: a meta-analysis","volume":"2017","author":"Zhu","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.clinre.2019.04.001_bib0040","first-page":"652","article-title":"Effect of non-alcoholic fatty liver disease on entecavir in treatment of chronic hepatitis B and insulin resistance","volume":"10","author":"Jiang","year":"2017","journal-title":"Chin J New Clin Med"},{"issue":"3","key":"10.1016\/j.clinre.2019.04.001_bib0045","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.clinre.2019.04.001_bib0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/00365513.2015.1125013","article-title":"Aspartate aminotransferase to platelet ratio index - a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues","volume":"76","author":"Peng","year":"2016","journal-title":"Scandinavian J Clin Laboratory Investigation"},{"key":"10.1016\/j.clinre.2019.04.001_bib0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-5926-4-10","article-title":"The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis","volume":"4","author":"Poynard","year":"2005","journal-title":"Comp Hepatol"},{"issue":"13","key":"10.1016\/j.clinre.2019.04.001_bib0060","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3748\/wjg.v16.i13.1560","article-title":"Liver fat content determined by magnetic resonance imaging and spectroscopy","volume":"16","author":"Springer","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.clinre.2019.04.001_bib0065","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1007\/s00330-009-1470-y","article-title":"Parametric exploration of the liver by magnetic resonance methods","volume":"19","author":"Sijens","year":"2009","journal-title":"Eur Radiol"},{"issue":"22","key":"10.1016\/j.clinre.2019.04.001_bib0070","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.3748\/wjg.14.3476","article-title":"Non-invasive means of measuring hepatic fat content","volume":"14","author":"Mehta","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clinre.2019.04.001_bib0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2009.05.023","article-title":"Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance","volume":"51","author":"Schwenzer","year":"2009","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2019.04.001_bib0080","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1478-3231.2012.02781.x","article-title":"Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography","volume":"32","author":"Myers","year":"2012","journal-title":"Liver Int"},{"issue":"11","key":"10.1016\/j.clinre.2019.04.001_bib0085","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"issue":"1","key":"10.1016\/j.clinre.2019.04.001_bib0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0043-123829","article-title":"Discordance in steatosis classification between liver biopsy and transient elastography for high controlled attenuation parameter (CAP) values","volume":"56","author":"Galaski","year":"2018","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.clinre.2019.04.001_bib0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"10.1016\/j.clinre.2019.04.001_bib0100","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1007\/s10620-013-2774-y","article-title":"Fatty liver disease index: a simple screening tool to facilitate diagnosis of nonalcoholic fatty liver disease in the Chinese population","volume":"58","author":"Fuyan","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2019.04.001_bib0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.nutr.22.012502.114457","article-title":"Ceruloplasmin metabolism and function","volume":"22","author":"Hellman","year":"2002","journal-title":"Annu Rev Nutr"},{"issue":"8","key":"10.1016\/j.clinre.2019.04.001_bib0110","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/BF02766076","article-title":"Biological functions of ceruloplasmin and their deficiency caused by mutation in genes regulating copper and iron metabolism","volume":"130","author":"Mzhel'skaya","year":"2000","journal-title":"Bull Exp Biol Med"},{"issue":"10","key":"10.1016\/j.clinre.2019.04.001_bib0115","first-page":"431","article-title":"Plasma copper and ceruloplasmin in patients with alcoholic liver steatosis","volume":"109","author":"Uhlikova","year":"2008","journal-title":"Bratisl Lek Listy"},{"issue":"1","key":"10.1016\/j.clinre.2019.04.001_bib0120","first-page":"13","article-title":"Ceruloplasmin level of patients with liver disease in China","volume":"44","author":"Yang","year":"2005","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"1","key":"10.1016\/j.clinre.2019.04.001_bib0125","first-page":"12","article-title":"Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis","volume":"14","author":"Koruk","year":"2003","journal-title":"Turkish J Gastroenterol"},{"issue":"4","key":"10.1016\/j.clinre.2019.04.001_bib0130","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MPG.0b013e31827aced4","article-title":"Levels of serum ceruloplasmin associate with pediatric nonalcoholic fatty liver disease","volume":"56","author":"Nobili","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"10.1016\/j.clinre.2019.04.001_bib0135","doi-asserted-by":"crossref","first-page":"e77942","DOI":"10.1371\/journal.pone.0077942","article-title":"Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease","volume":"8","author":"Zeng","year":"2013","journal-title":"PLoS One"},{"issue":"43","key":"10.1016\/j.clinre.2019.04.001_bib0140","doi-asserted-by":"crossref","first-page":"9586","DOI":"10.3748\/wjg.v22.i43.9586","article-title":"Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase","volume":"22","author":"Zeng","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2019.04.001_bib0145","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"European Association for the Study of the L. EASL clinical practice guidelines: management of chronic hepatitis B","volume":"50","year":"2009","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2019.04.001_bib0150","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.clinre.2019.04.001_bib0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.clinre.2019.04.001_bib0160","first-page":"3[49]2875","article-title":"Diagnostic accuracy and clinical utility of a new noninvasive index for hepatic steatosis in patients with hepatitis B virus infection","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep."},{"issue":"9","key":"10.1016\/j.clinre.2019.04.001_bib0165","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1373\/clinchem.2007.085795","article-title":"Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages","volume":"53","author":"Poynard","year":"2007","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.clinre.2019.04.001_bib0170","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI117127","article-title":"Intact human ceruloplasmin oxidatively modifies low density lipoprotein","volume":"93","author":"Ehrenwald","year":"1994","journal-title":"J Clin Investig"},{"key":"10.1016\/j.clinre.2019.04.001_bib0175","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.nutr.22.012502.114457","article-title":"Ceruloplasmin metabolism and function","volume":"22","author":"Hellman","year":"2002","journal-title":"Annu Rev Nutr"},{"issue":"8","key":"10.1016\/j.clinre.2019.04.001_bib0180","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metab Clin Exp"},{"issue":"2","key":"10.1016\/j.clinre.2019.04.001_bib0185","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jhep.2012.09.018","article-title":"Alterations in the redox state and liver damage: hints from the EASL Basic School of Hepatology","volume":"58","author":"Tell","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2019.04.001_bib0190","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.freeradbiomed.2013.08.174","article-title":"Free radical biology for medicine: learning from nonalcoholic fatty liver disease","volume":"65","author":"Serviddio","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.clinre.2019.04.001_bib0195","first-page":"127","article-title":"The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis","volume":"18","author":"Ucar","year":"2013","journal-title":"Redox Rep Commun Free Radical Res"},{"issue":"1","key":"10.1016\/j.clinre.2019.04.001_bib0200","first-page":"12","article-title":"Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis","volume":"14","author":"Koruk","year":"2003","journal-title":"Turk J Gastroenterol."},{"key":"10.1016\/j.clinre.2019.04.001_bib0205","first-page":"346","article-title":"V. G. Protein secretion, degradation and function","volume":"1","author":"Gerok","year":"1999"},{"issue":"4","key":"10.1016\/j.clinre.2019.04.001_bib0210","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI117127","article-title":"Intact human ceruloplasmin oxidatively modifies low density lipoprotein","volume":"93","author":"Ehrenwald","year":"1994","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.clinre.2019.04.001_bib0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4254\/wjh.v7.i2.177","article-title":"Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver","volume":"7","author":"Aigner","year":"2015","journal-title":"World J Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2019.04.001_bib0220","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ejim.2014.01.006","article-title":"Hepatitis B virus infection in patients with metabolic syndrome: a complicated relationship. Results of a population based study","volume":"25","author":"Jar\u010du\u0161ka","year":"2014","journal-title":"Eur J Internal Med"},{"issue":"7 Pt 1","key":"10.1016\/j.clinre.2019.04.001_bib0225","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1440-1746.2008.05478.x","article-title":"Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors","volume":"23","author":"Peng","year":"2008","journal-title":"J Gastroenterol Hepatol."},{"issue":"12","key":"10.1016\/j.clinre.2019.04.001_bib0230","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1136\/gut.2009.186668","article-title":"Haemoglobin and non-alcoholic fatty liver disease: further evidence from a population-based study","volume":"58","author":"Xu","year":"2009","journal-title":"Gut."},{"issue":"1","key":"10.1016\/j.clinre.2019.04.001_bib0235","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jhep.2011.05.027","article-title":"Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease","volume":"56","author":"Yu","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2019.04.001_bib0240","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0168-8278(01)00254-9","article-title":"Serum ceruloplasmin and ferroxidase activity are decreased in HFE C282Y homozygote male iron-overloaded patients","volume":"36","author":"Lain\u00e9","year":"2002","journal-title":"J Hepatol."},{"issue":"5","key":"10.1016\/j.clinre.2019.04.001_bib0245","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4254\/wjh.v6.i5.274","article-title":"Gender and racial differences in nonalcoholic fatty liver disease","volume":"6","author":"Pan","year":"2014","journal-title":"World J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2019.04.001_bib0250","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv Ther"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740119300907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740119300907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:29:10Z","timestamp":1761895750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740119300907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2210740119300907"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2019.04.001","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel predictive models using serum ceruloplasmin levels for hepatic steatosis in patients with chronic hepatitis B infection","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2019.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}